RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Efficacy and safety of glimepiride/metformin sustained release once daily vs. glimepiride/metformin twice daily in patients with type 2 diabetes.

Efficacy and safety of glimepiride/metformin sustained release once daily vs. glimepiride/metformin twice daily in patients with type 2 diabetes.

Add to Collection
2013 Mar Others Fist_Author_Year_PM

Full Author : ['Hwang, Y-C', 'Kang, M', 'Ahn, C W', 'Park, J S', 'Baik, S H', 'Chung, D J', 'Jang, H C', 'Kim, K-A', 'Lee, I-K', 'Min, K W', 'Nam, M', 'Park, T S', 'Son, S M', 'Sung, Y-A', 'Woo, J-T', 'Park, K S', 'Lee, M-K']
Journal Title : International journal of clinical practice
Chapter : Section3
Journal Year : 2013
Cited by : Not Available

AIMS: The study investigated the clinical equivalence in reducing haemoglobin A1c (A1C) between glimepiride/metformin sustained release (GM-SR) 2/500 mg, a fixed-dose combination, once daily and glimepiride/metformin (GM) 1/250 mg, a fixed-dose combinatio.....

Keywords : ["daily vs glimepiridemetformin twice daily", "glimepiridemetformin sustain release", "type diabetes", "safety", "patient", "efficacy"]